Results 121 to 130 of about 3,708 (185)

[Preventive activities in women's care]. [PDF]

Aten Primaria, 2020
López García-Franco A, Baeyens Fernández JA, Bailón Muñoz E, Iglesias Piñeiro MJ, Ortega Del Moral A, Coello PA, Ruiz Cabello C, Landa Goñi J, Arribas Mir L, Grupo de la Mujer del PAPPS.   +9 more
europepmc   +1 more source

Drug-related jaw osteonecrosis: a 6-year retrospective study from two centers in Argentina. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Leonardi N, Gilligan G, Garola F, Piemonte E, Panico R.   +4 more
europepmc   +1 more source

Estudio de cohortes retrospectivo en mujeres mayores de 75 años en tratamiento con bifosfonatos durante más de 10 años [PDF]

, 2015
Alfaro, Elena, Arnal, Elba, Ayuda, Clara, Doncel, Bárbara, Navarro, Victor, Rueda, Raquel   +5 more
core  

[Multiple vertebral fractures after rebound effect of denosumab in postmenopausal woman]. [PDF]

Aten Primaria
Ricart Torres E.
europepmc   +1 more source

[Evaluation of primary adherence to medications in patients with chronic conditions: A retrospective cohort study]. [PDF]

Aten Primaria, 2018
Peper FE, Esteban S, Terrasa SA.
europepmc   +1 more source

Biomechanical Gait Analysis in Patients with Osteonecrosis of the Femoral Head. [PDF]

Rev Bras Ortop (Sao Paulo), 2023
Schleder JSEL, Ramello DCS, Caron MD, Cliquet Junior A.   +3 more
europepmc   +1 more source

Doença Óssea no Mieloma Múltiplo [PDF]

, 2013
João Pedro Madeira Ribeirinho Soares
core  

[Photobiomodulation with active oxygen and lactoferrin in the treatment of medication-related osteonecrosis of the jaw. A case report]. [PDF]

Rev Cient Odontol (Lima)
Sánchez Ramírez C, de Santiago L, Bernotti A, Moreno Garcés P, de Jesús É, Miselli A, Villarroel Dorrego M.   +6 more
europepmc   +1 more source

[Facing a dilemma in elderly complex and vulnerable patients: to stop or not to stop prevention?] [PDF]

Aten Primaria, 2018
Llobet Vila L, Manresa Domínguez JM, Carmona Segado JM, Franzi Sisó A, Vallès Balasch R, Martínez Díaz I.   +5 more
europepmc   +1 more source

Osteonecrose maxilar associada ao uso de bifosfonatos

, 2018
Os bifosfonatos (BFs) são medicamentos usados principalmente no tratamento de algumas complicações de cancros sólidos, osteoporose, mieloma múltiplo e doença de Paget. Desde 2002 começaram a surgir pela Food and Drug Administration (FDA), relatórios de osteonecrose nos maxilares em doentes medicados com estes fármacos, inicialmente em doentes em ...
openaire   +1 more source